Welcome to LookChem.com Sign In|Join Free
  • or
(S)-3-(Dibenzylamino)pyrrolidin-2-one is a chiral chemical compound belonging to the class of pyrrolidinone derivatives. It features a specific three-dimensional structure that has garnered interest in various fields due to its potential pharmacological properties. (S)-3-(Dibenzylamino)pyrrolidin-2-one has been explored for its use as a chiral auxiliary in asymmetric synthesis, a building block in the development of new pharmaceuticals, and as a catalyst in chemical reactions. Its role in medicinal chemistry research and potential applications in drug discovery and development make it a promising candidate for further investigation.

235425-03-3

Post Buying Request

235425-03-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

235425-03-3 Usage

Uses

Used in Pharmaceutical Industry:
(S)-3-(Dibenzylamino)pyrrolidin-2-one is used as a chiral auxiliary for enhancing the selectivity and efficiency of asymmetric synthesis, which is crucial in the production of enantiomerically pure drugs. Its ability to influence the stereochemistry of synthesized compounds makes it a valuable tool in the development of new medications with fewer side effects and improved efficacy.
Used in Catalyst Development:
As a potential catalyst, (S)-3-(Dibenzylamino)pyrrolidin-2-one is utilized in various chemical reactions to increase the rate of these processes and improve overall yields. Its application in catalysis can lead to more sustainable and efficient chemical production methods, reducing waste and energy consumption.
Used in Medicinal Chemistry Research:
(S)-3-(Dibenzylamino)pyrrolidin-2-one serves as a building block in the design and synthesis of novel pharmaceuticals. Its unique structure allows for the creation of new molecules with potential therapeutic applications, contributing to the advancement of drug discovery and development.
Used in Drug Discovery and Development:
In the field of drug discovery and development, (S)-3-(Dibenzylamino)pyrrolidin-2-one is employed for its potential to contribute to the creation of new drugs with specific targeting and therapeutic properties. Its role in this process is vital, as it can lead to the discovery of innovative treatments for various diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 235425-03-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,5,4,2 and 5 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 235425-03:
(8*2)+(7*3)+(6*5)+(5*4)+(4*2)+(3*5)+(2*0)+(1*3)=113
113 % 10 = 3
So 235425-03-3 is a valid CAS Registry Number.

235425-03-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (3S)-3-(dibenzylamino)pyrrolidin-2-one

1.2 Other means of identification

Product number -
Other names (S)-3-(Dibenzylamino)pyrrolidin-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:235425-03-3 SDS

235425-03-3Relevant academic research and scientific papers

Chemo- and regioselective syntheses of enantiopure aminopyrrolidinones as building blocks for constrained peptidomimetics

Lehmann, Thomas,Michel, Dorothee,Glaenzel, Markus,Waibel, Reiner,Gmeiner, Peter

, p. 1389 - 1400 (2007/10/03)

Starting from natural asparagine the synthesis of the N-protected enantiomerically pure 3- and 4-aminopyrrolidinones (1) and (3) was accomplished. The incorporation of these building blocks into conformationally constrained peptidomimetics was demonstrated by the synthesis of the potential dopamine receptor modulator (14b) (β-PAOPA). Furthermore, Freidinger γ-lactams including the protected dipeptide mimetics (8a-c) and (9) were prepared. The optical integrity of the synthesis was established by NMR analysis of the ureas (10a,b).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 235425-03-3